Scottish Enterprise
Status
ACTIVE
Global HQ
Glasgow, United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Seed
- Series A
- Series B
Industries
- Health Tech
About
Scottish Enterprise plays a crucial role in fostering Scotland’s innovation economy by co-investing in high-potential startups and scale-ups across a wide range of sectors. The firm emphasizes supporting companies that have export potential and can contribute significantly to job creation. Scottish Enterprise aims to foster innovation and economic growth, from early-stage startups to more mature companies, with a focus on helping them scale sustainably and achieve long-term success in global markets.
Scottish Enterprise plays a crucial role in fostering Scotland’s innovation economy by co-investing in high-potential startups and scale-ups across a wide range of sectors. The firm emphasizes supporting companies that have export potential and can contribute significantly to job creation. Scottish Enterprise aims to foster innovation and economic growth, from early-stage startups to more mature companies, with a focus on helping them scale sustainably and achieve long-term success in global markets.
Investment Thesis
Scottish Enterprise’s investment thesis revolves around driving Scotland’s long-term economic growth by backing innovation, entrepreneurship, and global competitiveness. It co-invests alongside private investors in high-potential sectors such as renewables, life sciences, manufacturing, and digital technologies. The organization aims to stimulate private-sector innovation, job creation, and export growth while fostering a resilient national innovation ecosystem.
Manager's Experience
Government-backed team with diverse investment experience across sectors, supporting regional innovation and business growth.
Team
Adrian Gillespie – Chief Executive
Jane Martin – Managing Director of Innovation and Investment
Gill McNeill – Chief People Officer of People
Digital and Communications
Rhona Allison – Managing Director of Productivity and Business Growth
Kerry Sharp – Chief Finance & Investment Officer
Reuben Aitken – Managing Director
Energy Transition and International Operations.
Portfolio
Amphista Therapeutics
Dyneval
ReproCell Europe
MGB Biopharma
NovaBiotics
EnteroBiotix
ENOUGH
Roslin Technologies
Calcivis
Celtic Renewables